Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance.

Autor: Sandri, Silvana1 (AUTHOR), Watanabe, Luis R.M.1 (AUTHOR), Oliveira, Erica Aparecida de1 (AUTHOR), Faião-Flores, Fernanda1 (AUTHOR), Migliorini, Silene1 (AUTHOR), Tiago, Manoela1 (AUTHOR), Felipe-Silva, Aloisio2 (AUTHOR), Vazquez, Vinícius de Lima3 (AUTHOR), da Costa Souza, Paola4 (AUTHOR), Consolaro, Márcia Edilaine Lopes5 (AUTHOR), Campa, Ana1 (AUTHOR), Maria-Engler, Silvya Stuchi1 (AUTHOR) silvya@usp.br
Zdroj: Pharmacological Research. Sep2020, Vol. 159, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate